Although these studies indicated that the increasing expression of HDAC2 was associated with tumor progression, our study is the first to demonstrate a clear correlation between HDAC2 expression and advanced stage ovarian cancer (Table II). Here, HDAC2 is linked to ovarian carcinoma.